» Authors » Rodrigo C de Almeida

Rodrigo C de Almeida

Explore the profile of Rodrigo C de Almeida including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 58
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Augusto D, de Almeida R, Farias T, Magalhaes W, Malheiros D, Lima-Costa M, et al.
J Invest Dermatol . 2021 May; 141(11):2741-2744. PMID: 33991537
No abstract available.
2.
Schauren J, Torres A, de Almeida R, Santos P, Mulinari-Brenner F, Lima L, et al.
Clin Genet . 2019 Nov; 97(3):529-531. PMID: 31696509
No abstract available.
3.
Sugita B, Pereira S, de Almeida R, Gill M, Mahajan A, Duttargi A, et al.
Oncotarget . 2019 Nov; 10(58):6184-6203. PMID: 31692930
Triple negative breast cancer (TNBC), a clinically aggressive breast cancer subtype, affects 15-35% of women from Latin America. Using an approach of direct integration of copy number and global miRNA...
4.
Chagas V, Groeneveld C, Oliveira K, Trefflich S, de Almeida R, Ponder B, et al.
Bioinformatics . 2019 Jun; 35(24):5357-5358. PMID: 31250887
Motivation: Transcription factors (TFs) are key regulators of gene expression, and can activate or repress multiple target genes, forming regulatory units, or regulons. Understanding downstream effects of these regulators includes...
5.
de Almeida R, Chagas V, Castro M, Petzl-Erler M
Front Genet . 2018 May; 9:139. PMID: 29755505
Genome-wide and fine mapping studies have shown that more than 90% of genetic variants associated with autoimmune diseases (AID) are located in non-coding regions of the human genome and especially...
6.
Cipolla G, Park J, de Oliveira L, Lobo-Alves S, de Almeida R, Farias T, et al.
Biochim Biophys Acta . 2016 Jul; 1859(10):1306-13. PMID: 27424220
Genetic variations mapping to 3' untranslated regions (3'UTRs) may overlap with microRNA (miRNA) binding sites, therefore potentially interfering with translation inhibition or messenger RNA (mRNA) degradation. The aim of this...
7.
Brouwer J, Kluiver J, de Almeida R, Modderman R, Terpstra M, Kok K, et al.
J Clin Pathol . 2016 Apr; PMID: 27048682
Aims: BRCA1 mutation carriers are at increased risk of developing high-grade serous ovarian cancer (HGSOC), a malignancy that originates from fallopian tube epithelium. We aimed to identify differentially expressed known...